Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.5M
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
5.92M
-
Shares change
-
+467K
-
Total reported value, excl. options
-
$11.9M
-
Value change
-
+$883K
-
Number of buys
-
30
-
Number of sells
-
-13
-
Price
-
$2.00
Significant Holders of FibroBiologics, Inc. - Common Stock (FBLG) as of Q4 2024
66 filings reported holding FBLG - FibroBiologics, Inc. - Common Stock as of Q4 2024.
FibroBiologics, Inc. - Common Stock (FBLG) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.92M shares
of 37.5M outstanding shares and own 15.78% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (1.79M shares), VANGUARD GROUP INC (912K shares), GEODE CAPITAL MANAGEMENT, LLC (605K shares), STATE STREET CORP (575K shares), Cascade Financial Partners, LLC (283K shares), NORTHERN TRUST CORP (215K shares), UBS Group AG (128K shares), Optivise Advisory Services LLC (110K shares), Requisite Capital Management, LLC (110K shares), and BANK OF AMERICA CORP /DE/ (89.9K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.